Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Biotage
OM:BIOT Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Biotage
Popular
Undervalued
Overvalued
Biotage
AN
Analyst Price Target
Consensus Narrative from 2 Analysts
New Product Launches Will Increase Peptide Purification Market Presence
Key Takeaways Strategic expansion in clinical Phase II and peptide purification markets aims to significantly boost future revenues and growth potential. Integration of Astrea and organizational changes are expected to improve operational efficiency, enhancing profit margins and cash flow.
View narrative
SEK 155.00
FV
33.4% undervalued
intrinsic discount
10.10%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
BIOT
Biotage
Your Fair Value
SEK
Current Price
SEK 103.30
18.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
3b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 3.3b
Earnings SEK 451.7m
Advanced
Set as Fair Value